Добірка наукової літератури з теми "Point-of-Care (PoC)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Point-of-Care (PoC)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Point-of-Care (PoC)"
Zubik, A. N., G. E. Rudnitskaya, A. A. Evstrapov, and T. A. Lukashenko. "POINT-OF-CARE (POC) DEVICES: CLASSIFICATION AND BASIC REQUIREMENTS." NAUCHNOE PRIBOROSTROENIE 32, no. 3 (August 30, 2022): 3–29. http://dx.doi.org/10.18358/np-32-3-i329.
Повний текст джерелаWeber, Christian Friedrich, Klaus Görlinger, Dirk Meininger, Eva Herrmann, Tobias Bingold, Anton Moritz, Lawrence H. Cohn, and Kai Zacharowski. "Point-of-Care Testing." Anesthesiology 117, no. 3 (September 1, 2012): 531–47. http://dx.doi.org/10.1097/aln.0b013e318264c644.
Повний текст джерелаWessels, Lars, Andreas Unterberg, and Christopher Beynon. "Point-of-Care Testing in Neurosurgery." Seminars in Thrombosis and Hemostasis 43, no. 04 (March 27, 2017): 416–22. http://dx.doi.org/10.1055/s-0037-1599159.
Повний текст джерелаFries, Dietmar, and Werner Streif. "Point-of-Care Testing in Critically Ill Patients." Seminars in Thrombosis and Hemostasis 41, no. 01 (January 22, 2015): 075–83. http://dx.doi.org/10.1055/s-0035-1544184.
Повний текст джерелаTanaka, Kenichi, and Daniel Bolliger. "Point-of-Care Coagulation Testing in Cardiac Surgery." Seminars in Thrombosis and Hemostasis 43, no. 04 (March 30, 2017): 386–96. http://dx.doi.org/10.1055/s-0037-1599153.
Повний текст джерелаDrancourt, Michel, Audrey Michel-Lepage, Sylvie Boyer, and Didier Raoult. "The Point-of-Care Laboratory in Clinical Microbiology." Clinical Microbiology Reviews 29, no. 3 (March 30, 2016): 429–47. http://dx.doi.org/10.1128/cmr.00090-15.
Повний текст джерелаStein, Philipp, Alexander Kaserer, Gabriela Spahn, and Donat Spahn. "Point-of-Care Coagulation Monitoring in Trauma Patients." Seminars in Thrombosis and Hemostasis 43, no. 04 (March 15, 2017): 367–74. http://dx.doi.org/10.1055/s-0037-1598062.
Повний текст джерелаCozma, Angela, Camelia Vonica, Adela Sitar-Taut, and Adriana Fodor. "Point-of-care testing in diabetes management." Revista Romana de Medicina de Laborator 27, no. 2 (April 1, 2019): 125–35. http://dx.doi.org/10.2478/rrlm-2019-0014.
Повний текст джерелаChamane, Nkosinothando, Desmond Kuupiel, and Tivani Phosa Mashamba-Thompson. "Stakeholders’ Perspectives for the Development of a Point-of-Care Diagnostics Curriculum in Rural Primary Clinics in South Africa—Nominal Group Technique." Diagnostics 10, no. 4 (April 1, 2020): 195. http://dx.doi.org/10.3390/diagnostics10040195.
Повний текст джерелаStraseski, Joely A., Martha E. Lyon, William Clarke, Jeffrey A. DuBois, Lois A. Phelan, and Andrew W. Lyon. "Investigating Interferences of a Whole-Blood Point-of-Care Creatinine Analyzer: Comparison to Plasma Enzymatic and Definitive Creatinine Methods in an Acute-Care Setting." Clinical Chemistry 57, no. 11 (November 1, 2011): 1566–73. http://dx.doi.org/10.1373/clinchem.2011.165480.
Повний текст джерелаДисертації з теми "Point-of-Care (PoC)"
Schenk, Sebastian [Verfasser]. "Vergleich von Point-of-Care (POC) Gerinnungsmessverfahren in der Kinderkardiochirurgie / Sebastian Schenk." Tübingen : Universitätsbibliothek Tübingen, 2020. http://d-nb.info/1219064793/34.
Повний текст джерелаRuiz, Vega Gisela. "One-step electrochemical magneto assays for the development of point-of-care (POC) diagnostic devices." Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/669860.
Повний текст джерелаUno de los mayores desafíos para monitorear y mejorar la salud de la población a nivel mundial es la falta de pruebas de diagnóstico apropiadas para la detección temprana de enfermedades, la selección de tratamientos apropiados y el seguimiento de pacientes a lo largo del tiempo. La disponibilidad de herramientas de diagnóstico suficientemente rápidas, sensibles y robustas es crucial para lograr el bienestar de los pacientes en todo el mundo. En este contexto, la nanotecnología y el desarrollo de biosensores son campos en rápida evolución que han generado grandes expectativas, produciendo pruebas más rápidas y más fáciles de realizar que la mayoría de los métodos clásicos. Los biosensores se han descrito en base al uso de una amplia variedad de elementos de biotecnología y tipos de transducción de señales. Entre ellos, los biosensores electroquímicos son el tipo más común en uso hoy en día gracias a la portabilidad y el bajo costo del equipo de medición, las medidas rápidas, robustas y cuantitativas proporcionadas, y la facilidad de miniaturización de todo el sistema de detección. La reciente incorporación de papel para la producción de electrodos impresos en papel y ensayos electroquímicos de flujo lateral está fomentando el desarrollo de dispositivos extremadamente económicos que, gracias a las propiedades fluídicas del papel, permiten reducir la complejidad del ensayo y el nivel de manipulación para el usuario final. Esto favorece el desarrollo de dispositivos de diagnóstico de \”Point-of-care\” (POC), que pueden ser utilizados directamente por el paciente o en los centros de atención primaria de salud. Por otro lado, las partículas magnéticas (PM) se han utilizado con gran éxito en la optimización de los magneto-biosensores. Las PM son atractivos para este propósito porque, una vez modificados con un bioreceptor apropiado, otorgan una preconcentración simple, rápida y específica del analito objetivo. Las PM también ofrecen superficies activas en 3D relativamente grandes, que se mezclan bajo agitación constante con las muestras y permiten una rápida unión con los analitos. Sin embargo, las PM también presenta limitaciones, como su manejo tedioso y lento que solo está al alcance de usuarios altamente capacitados. El objetivo principal de este proyecto de tesis doctoral fue la producción de magneto-biosensores electroquímicos rápidos, fáciles de realizar, robustos y sensibles para la detección de biomarcadores de diagnóstico en muestras de suero, plasma y sangre. Como se mostrará, esto se ha logrado en dos niveles. Primero, desarrollando un formato de magneto-inmunoensayo extremadamente rápido y simple. En segundo lugar, fabricando electrodos de papel microfluidos simples y económicos, que fueron explotados para llevar a cabo en el chip la mayoría de los pasos del magneto-inmunoensayo simplificado con la mínima intervención del usuario.
One of the greatest challenges for monitoring and improving the health of the population at a global level is the lack of appropriate diagnostic tests for early detection of diseases, selection of appropriate treatments and patient follow-up over time. The availability of sufficiently fast, sensitive and robust diagnostic tools will be crucial to achieve patients’ well-being worldwide. In this context, nanotechnology and biosensor development are rapidly evolving fields that have generated great expectations, producing tests faster and easier to carry out than most classical methods. Biosensors have been described based on the use of a wide variety of biotechnology elements and types of signal transduction. Among them, electrochemical biosensors are the most common type in use today thanks to the portability and low cost of the measuring equipment, fast, robust and quantitative measures provided, and easiness of miniaturization of the whole detection system. The recent incorporation of paper and paper-like materials for the production of paper printed electrodes and lateral flow electrochemical assays is fostering the development of extremely inexpensive devices that, thanks to the fluidic properties of paper, allow reducing assay complexity and level of manipulation for the end user. This favours the development of "Point-of-Care" diagnostic devices (POC), which can be used directly by the patient or at primary health care centres. On the other hand, magnetic beads (MB) have been used with great success in the optimization of magneto-biosensors. MB are attractive for this purpose because, once modified with an appropriate bioreceptor, they grant simple, rapid and specific preconcentration of the targeted analyte. MB offer also relatively large 3D active surfaces, which mixed under constant agitation with the sample supply efficient and fast analyte binding as well. Nevertheless, MB display limitations too, requiring tedious and time-consuming handling that is only at reach of highly trained users. The main objective of this PhD Thesis project was the production of rapid, easy to perform, robust and sensitive electrochemical magneto-biosensors for the detection of diagnostic biomarkers in serum, plasma and blood samples. As it will be shown, this has been achieved at two levels. First, by developing an extremely fast and simple magnetoimmunoassay format. Second, by fabricating simple and inexpensive microfluidic paper electrodes, which were exploited to carry out on-chip most of the steps of the simplified magneto-immunoassay with minimal user intervention.
Lightowler, Bryan, and Anthony Hoswell. "Can handheld POC capillary lactate measurement be used with arterial and venous laboratory testing methods in the identification of sepsis?" Mark Allen Group, 2016. http://hdl.handle.net/10454/18605.
Повний текст джерелаThe aim of this review was to examine whether the measurement of lactate in capillary blood samples using point-of-care handheld analysers corresponds sufficiently closely with arterial and venous whole-blood samples analysed by hospital central laboratory or blood gas analyser to be used interchangeably. A systematic search, informed by focused inclusion/exclusion criteria, was performed using multiple databases up to October 2015. A total of 65 articles were considered to have potential relevance and were evaluated in full text, of which ultimately five articles met all inclusion/exclusion criteria, and a final four were selected after data extraction and quality appraisal. All four studies found a predominantly upward bias in the measurement of lactate in capillary samples tested using a handheld point-of-care device over arterial or venous samples tested by laboratory methods or blood gas analyser. In terms of correlation, there was consensus between the studies that the strength of association between the two methods of measurement was statistically significant. Three studies directly examined the extent of agreement between point-of-care capillary lactate measurements and those of laboratory or blood gas analyser reference determined to ±2 standard deviations; 95% confidence intervals, and report contextually broad limits of agreement, identifying a potential for both over triage and, to a lesser extent, under triage. The findings of the review do not support interchangeable use of handheld fingertip point-of-care lactate measurement with laboratory or blood gas analyser methods in the identification of sepsis.
Godfrey, Trevor M. "Going for Gold: Point of Care Bio-Diagnostics and Gold Nanoparticles Treating Disease." BYU ScholarsArchive, 2021. https://scholarsarchive.byu.edu/etd/8917.
Повний текст джерелаEmeka-Nweze, Chika Cornelia. "ICU_POC: AN EMR-BASED POINT OF CARE SYSTEM DESIGN FOR THE INTENSIVE CARE UNIT." Case Western Reserve University School of Graduate Studies / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=case1499255523449397.
Повний текст джерелаFerreira, Daniela Lina Alves. "Abordagem clínica de intoxicações em canídeos por inseticidas anticolinesterásicos e utilização de testes imediatos (point of care)." Master's thesis, Universidade de Lisboa. Faculdade de Medicina Veterinária, 2015. http://hdl.handle.net/10400.5/10489.
Повний текст джерелаPerante a suspeita de intoxicação aguda, a abordagem célere e sistemática ao doente, permite uma rápida prestação de cuidados específicos. A triagem, recolha da história clínica, avaliação e intervenção médica de urgência, o diagnóstico e a terapêutica são processos chave nessa abordagem. O diagnóstico, por norma, é suportado por um painel analítico inicial. O recurso a testes imediatos (“point of care”), permite avaliar não só a condição geral dos doentes em tempo real, mas também os efeitos que os xenobióticos possam ter a nível orgânico e que se traduzam, nomeadamente, em alterações do equilíbrio hidroeletrólitico e estado ácido base. O presente estudo pretendeu avaliar as alterações analíticas, detetadas através da ferramenta ePOC (“Enterprise Point of Care”), em animais suspeitos de intoxicação por inseticidas anticolinesterásicos e a sua eventual influência no diagnóstico e implementação da terapêutica. A amostra estudada consistiu em 14 canídeos, que na triagem médica apresentavam sintomas inespecíficos e outros compatíveis com intoxicação aguda por insecticidas anticolinesterásicos: tremores musculares (93%), hipersiália (64%), hipertermia (57%), cianose (50%), diarreia (57%) e vómito (36%). Foram colhidas amostras de sangue para a realização do teste ePOC e para ulterior análise toxicológica.Os resultados obtidos através do ePOC mostraram diminuição da pressão parcial de dióxido de carbono (pCO2) (64%), aumento da concentração de lactato (36%), aumento dos valores de hemoglobina e hematócrito (50%), hiperglicémia (36%) e aumento dos valores de creatinina (50%), não havendo, contudo, relação estatisticamente significativa entre as variáveis testadas e o diagnóstico toxicológico (p>0.05). Porém, em todos os animais considerados acidémicos houve detecção de compostos do grupo dos inseticidas anticolinesterásicos na análise toxicológica. O estudo clínico individualizado de cada caso permitiu verificar que, apesar da sintomatologia similar, os animais apresentavam distúrbios ácido-base diferentes, sendo por isso também necessária uma abordagem terapêutica diferenciada, fulcral especialmente em condições críticas. Estudos futuros, com uma amostra de maior dimensão e preferencialmente com exposição a diferentes xenobióticos, poderão permitir uma avaliação mais exata e abrangente da relação entre a etiologia das intoxicações e as alterações hidroeletrolíticas e de gases sanguíneas verificadas.
ABSTRACT - Clinical Approach to Poisoning in Canidae by Anticholinesterase Insecticides and use of immediate tests (Point of Care) - Faced with a suspected acute intoxication, a prompt and systematic approach to the patient, allows a fast provision of specific care. The triage, history taking, assessment and emergency medical intervention, diagnosis and treatment are key processes in this approach. The diagnosis is usually supported by an initial analytic panel. The use of immediate testing ("point of care"), allows the evaluation, not only of the patient’s general condition in real time, but also the effects that xenobiotics may have at an organic level, which may result in electrolyte and acid base disorders. The presente study intended to evaluate the analytical changes detected by ePOC ("Enterprise Point of Care") in animals suspected of poisoning by anticholinesterase insecticides and their possible influence on the diagnostic and therapeutic implementation. The sample consisted of 14 canines, which had nonspecific symptoms and other compatible with acute poisoning by anticholinesterase insecticides: muscle tremors (93%), hypersialia (64%), fever (57%), cyanosis (50%), diarrhea (57%) and vomiting (36%). Blood samples were collect to perform ePOC testing and for further toxicological analysis. Analytical changes (ePOC) showed a decreased partial pressure of carbon dioxide (pCO2) (64%), an increased lactate concentration (36%), na increase in hemoglobin and hematocrit levels (50%), hyperglycemia (36%) and an increased serum creatinine values (50%), without, however, statistically significant relationship between the variables tested and toxicological diagnosis (p> 0.05). Nevertheless, in all animals considered acidemic, toxicological analysis showed the detection of anticholinesterase insecticides. The individualized clinical study of each case has shown, that despite the similar symptoms, the animals had different acid-base disorders and is, therefore, also required a different therapeutic approach, especially in critical conditions. Further studies with a larger sample and preferably with exposure to different xenobiotics may allow a more accurate and comprehensive evaluation of the relationship between the etiology of poisoning and blood gas and electrolyte changes observed.
Oosthuizen, Louzanne. "A location science model for the placement of POC CD4 testing devices as part of South Africa's public healthcare diagnostic service delivery model." Thesis, Stellenbosch : Stellenbosch University, 2015. http://hdl.handle.net/10019.1/96972.
Повний текст джерелаENGLISH ABSTRACT: South Africa has a severe HIV (human immunodeficiency virus) burden and the management of the disease is a priority, especially in the public healthcare sector. One element of managing the disease, is determining when to initiate an HIV positive individual onto anti-retroviral therapy (ART), a treatment that the patient will remain on for the remainder of their lifetime. For the majority of HIV positive individuals in the country, this decision is governed by the results of a CD4 (cluster of differentiation 4) test that is performed at set time intervals from the time that the patient is diagnosed with HIV until the patient is initiated onto ART. A device for CD4 measurement at the point of care (POC), the Alere PIMA™, has recently become commercially available. This has prompted a need to evaluate whether CD4 testing at the POC (i.e. at the patient serving healthcare facility) should be incorporated into the South African public healthcare sector's HIV diagnostic service provision model. One challenge associated with the management of HIV in the country is the relatively large percentage of patients that are lost to follow-up at various points in the HIV treatment process. There is extensive evidence that testing CD4 levels at the POC (rather than in a laboratory, as is the current practice) reduces the percentage of patients that are lost to follow-up before being initiated onto ART. Therefore, though POC CD4 testing is more expensive than laboratory-based CD4 testing, the use of this technology in South Africa should be investigated for its potential to positively influence health outcomes. In this research, a multi-objective location science model is used to generate scenarios for the provision of CD4 testing capability. For each scenario, CD4 testing provision at 3 279 ART initiation facilities is considered. For each facility, either (i) a POC device is placed at the site; or (ii) the site's testing workload is referred to one of the 61 CD4 laboratories in the country. To develop this model, the characteristics of eight basic facility location models are compared to the attributes of the real-world problem in order to select the most suitable one for application. The selected model's objective, assumptions and inputs are adjusted in order to adequately model the realworld problem. The model is solved using the cross-entropy method for multi-objective optimisation and the results are verified using a commercial algorithm. Nine scenarios are selected from the acquired Pareto set for detailed presentation. In addition, details on the status quo as well as a scenario where POC testing is used as widely as possible are also presented. These scenarios are selected to provide decision-makers with information on the range of options that should be considered, from no or very limited use to widespread use of POC testing. Arguably the most valuable contribution of this research is to provide an indication of the optimal trade-off points between an improved healthcare outcome due to POC CD4 testing and increased healthcare spending on POC CD4 testing in the South African public healthcare context. This research also contributes to the location science literature and the metaheuristic literature.
AFRIKAANSE OPSOMMING: Suid-Afrika gaan gebuk onder `n swaar MIV- (menslike-immuniteitsgebreksvirus-) las en die bestuur van die siekte is `n prioriteit, veral in die openbare gesondheidsorgsektor. Een element in die bestuur van die siekte is om te bepaal wanneer `n MIV-positiewe individu met antiretrovirale- (ARV-)behandeling behoort te begin, waarop pasiënte dan vir die res van hul lewens bly. Vir die meeste MIV-positiewe individue in die land word hierdie besluit bepaal deur die uitslae van `n CD4- (cluster of differentiation 4-)toets wat met vasgestelde tussenposes uitgevoer word vandat die pasiënt met MIV gediagnoseer word totdat hy of sy met ARV-behandeling begin. `n Toestel vir CD4-meting by die punt van sorg (\POC"), die Alere PIMA™, is onlangs kommersieel beskikbaar gestel. Dit het `n behoefte laat ontstaan om te bepaal of CD4-toetsing by die POC (met ander woorde, by die gesondheidsorgfasiliteit waar die pasiënt bedien word) by die MIV-diagnostiese diensleweringsmodel van die Suid-Afrikaanse openbare gesondheidsorgsektor ingesluit behoort te word. Een uitdaging met betrekking tot MIV-bestuur in die land is die betreklik groot persentasie pasiënte wat verlore gaan vir nasorg in die verskillende stadiums van die MIV-behandelingsproses. Heelwat bewyse dui daarop dat die toetsing van CD4-vlakke by die POC (eerder as in `n laboratorium, soos wat tans die praktyk is) die persentasie pasiënte wat verlore gaan vir nasorg voordat hulle met ARV-behandeling kan begin, verminder. Daarom, hoewel CD4-toetsing by die POC duurder is as toetsing in `n laboratorium, behoort die gebruik van hierdie tegnologie in Suid-Afrika ondersoek te word. In hierdie studie is `n meerdoelige liggingswetenskapmodel gebruik om scenario's vir die voorsiening van CD4-toetsvermoë te skep. Vir elke scenario word CD4-toetsvermoë by 3 279 ARV-inisiasie fasiliteite oorweeg. Vir elke fasiliteit word toetsvermoë verskaf deur (i) die plasing van POC-toestelle by die fasiliteit, of (ii) verwysing vir laboratoriumgebaseerde toetsing by een van die 61 CD4-laboratoriums in die land. Die kenmerke van agt basiese fasiliteitsliggingsmodelle is met die kenmerke van die werklike probleem vergelyk om die mees geskikte model vir toepassing op die werklike probleem te bepaal. Die doelwitte, aannames en insette van die gekose model is daarna aangepas om die werklike probleem voldoende te modelleer. Die model is opgelos met behulp van die kruis-entropie-metode vir meerdoelige optimering, waarna die resultate deur middel van `n kommersiële algoritme bevestig is. Nege scenario's uit die verworwe Pareto-stel word uitvoerig aangebied. Daarbenewens beskryf die studieresultate die besonderhede van die status quo sowel as `n scenario waar POC-toetsing so wyd moontlik gebruik word. Hierdie scenario's word aangebied om besluitnemers van inligting te voorsien oor die verskeidenheid moontlikhede wat oorweeg kan word, wat wissel van geen of baie beperkte tot wydverspreide gebruik van POC-toetsing. Die mees beduidende bydrae van hierdie navorsing is stellig dat dit `n aanduiding bied van die optimale kompromie tussen `n verbeterde gesondheidsorguitkoms weens CD4-toetsing by die POC, en verhoogde gesondheidsorgbesteding aan CD4-toetsing by die POC, in die konteks van Suid-Afrikaanse openbare gesondheidsorg. Die navorsing dra ook by tot die ligingswetenskapliteratuur sowel as tot die metaheuristiekliteratuur.
Azimi, Sayyed Mohamad. "Magnetic bead-based DNA extraction and purification microfluidic chip." Thesis, Brunel University, 2010. http://bura.brunel.ac.uk/handle/2438/4520.
Повний текст джерелаBjuhr, Mathias, Christian Berne, and Anders Larsson. "External Quality Assessment of HbA1c for Point of Care Testing." Thesis, Uppsala University, Department of Medical Biochemistry and Microbiology, 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7850.
Повний текст джерелаObjectives: To evaluate the long term total imprecision of HbA1c testing within the county of Uppsala in relation to the Swedish analytical goal of coefficient of variation (CV) <3% for HbA1c and to study the cost of an external quality assurance program for point-of-care HbA1c The county uses Bayer DCA 2000™ for point-of care HbA1c testing currently having 23 of these instruments.
Methods: Method imprecision was assessed by analysis of patient samples performed as split samples during a 3 year period (2002-2004) as part of the quality assurance program for point-of-care HbA1c testing. The samples were first analysed on a Bayer DCA 2000™ and the samples were then sent to the centralised laboratory for reanalysis with an HPLC system (Variant II™, Biorad). The testing was performed approximately 8 times per year with each instrument.
Results: The median CV between the HPLC method and the point-of-care instruments for each unit was slightly higher than 3%.
Conclusion: The DCA 2000™ systems have an acceptable imprecision and agreement with the central laboratory. The test results show acceptable agreements within the county regardless where the patient is tested. The cost of the external quality assurance program is calculated to be approximately SEK 1340 (Euro 150) per instrument.
Aggarwal, Kashish. "An Android Based Portable Analyzer System for Point-of-care-testing(POCT) Immunodiagnostics." University of Cincinnati / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1543586356137427.
Повний текст джерелаКниги з теми "Point-of-Care (PoC)"
Medical Biosensors for Point of Care (POC) Applications. Elsevier, 2017. http://dx.doi.org/10.1016/c2014-0-01459-1.
Повний текст джерелаNarayan, Roger J. Medical Biosensors for Point of Care (POC) Applications. Elsevier Science & Technology, 2016.
Знайти повний текст джерелаNarayan, Roger J. Medical Biosensors for Point of Care (POC) Applications. Elsevier Science & Technology, 2016.
Знайти повний текст джерелаImplementation and Scale Up of Point of Care (POC) Diagnostics in Resource-Limited Settings. MDPI, 2020. http://dx.doi.org/10.3390/books978-3-03943-171-7.
Повний текст джерелаMorgan, Douglas E. Point-of-Care Testing (DRAFT). Edited by Raghavan Murugan and Joseph M. Darby. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190612474.003.0030.
Повний текст джерелаXu, Tailin, and Yunlu Pan, eds. Integrated Point-of-care Testing (POCT) Systems: Recent Progress and Applications. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-739-9.
Повний текст джерелаStaff, IEEE. 2022 IEEE Healthcare Innovations and Point of Care Technologies (HI POCT). IEEE, 2022.
Знайти повний текст джерелаShephard OAM, Mark, ed. Practical Guide to Global Point-of-Care Testing. CSIRO Publishing, 2016. http://dx.doi.org/10.1071/9781486305193.
Повний текст джерелаЧастини книг з теми "Point-of-Care (PoC)"
Lefebvre, Cedric W., Jay P. Babich, James H. Grendell, James H. Grendell, John E. Heffner, Ronan Thibault, Claude Pichard, et al. "Point of Care (POC) Coagulation Analyzers." In Encyclopedia of Intensive Care Medicine, 1785. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_3251.
Повний текст джерелаVinayaka, Aaydha Chidambara, Than Linh Quyen, Mohsen Golabi, Trieu Nguyen, Van Ngoc Huynh, Dang Duong Bang, and Anders Wolff. "New-Generation Molecular Techniques in POC Biosensors for Detection of Infectious Diseases." In Nanobiosensors for point-of-care medical diagnostics, 79–106. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-5141-1_4.
Повний текст джерелаBoldt, J. "Point-Of-Care (POC) Monitoring of Coagulation in the Critically Ill." In Yearbook of Intensive Care and Emergency Medicine, 570–76. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-662-13453-5_49.
Повний текст джерелаShekane, Paul. "Is Point-of-Care (POC) Coagulation Testing Worthwhile Before Regional or Neuraxial Anesthesia?" In You’re Wrong, I’m Right, 337–38. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43169-7_97.
Повний текст джерелаLewis, Gregory G., and Scott T. Phillips. "Quantitative Point-of-Care (POC) Assays Using Measurements of Time as the Readout: A New Type of Readout for mHealth." In Methods in Molecular Biology, 213–29. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-2172-0_15.
Повний текст джерелаMuhammad, Imran, and Nilmini Wickramasinghe. "An Evaluation of the Point-of-Care (PoC) System Implementation and Adoption in a Multi-Campus Private Hospital in Melbourne." In Healthcare Delivery in the Information Age, 535–54. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-17347-0_26.
Повний текст джерелаGässler, Norbert, Peter B. Luppa, Andreas Bietenbeck, Astrid Petersmann, Alexander Pröbstl, Daniel Romann, and Ralf Junker. "Implementation of POCT." In Point-of-Care Testing, 303–12. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-54497-6_31.
Повний текст джерелаBietenbeck, Andreas, and Siegfried Jedamzik. "POCT in telemedicine." In Point-of-Care Testing, 333–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-54497-6_35.
Повний текст джерелаVashist, Sandeep K., John H. T. Luong, Peter B. Luppa, and Ralf Junker. "Future POCT systems." In Point-of-Care Testing, 413–20. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-54497-6_41.
Повний текст джерелаLuppa, Peter B., Christoph Braun, and Andreas Bietenbeck. "POCT and data management." In Point-of-Care Testing, 269–79. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-54497-6_27.
Повний текст джерелаТези доповідей конференцій з теми "Point-of-Care (PoC)"
Sibbitt, John P., and Mei He. "3D Printing of Microfluidics for Point of Care Diagnosis." In ASME 2017 12th International Manufacturing Science and Engineering Conference collocated with the JSME/ASME 2017 6th International Conference on Materials and Processing. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/msec2017-2778.
Повний текст джерелаLeary, James F. "Design of point-of-care (POC) microfluidic medical diagnostic devices." In Microfluidics, BioMEMS, and Medical Microsystems XVI, edited by Bonnie L. Gray and Holger Becker. SPIE, 2018. http://dx.doi.org/10.1117/12.2286542.
Повний текст джерелаMartínez-López, J. Israel, Mauricio Mojica, H. A. Betancourt, Ciro A. Rodríguez, and Héctor R. Siller. "Xurography and Lamination for Manufacturing Point-of-Care (POC) Micromixers." In 4M/IWMF2016 The Global Conference on Micro Manufacture : Incorporating the 11th International Conference on Multi-Material Micro Manufacture (4M) and the 10th International Workshop on Microfactories (IWMF). Singapore: Research Publishing Services, 2016. http://dx.doi.org/10.3850/978-981-11-0749-8_722.
Повний текст джерелаPerumal, Jayakumar, Ran Zhi Tong Chua, Mohesh Moothanchery, Poongkulali Rajarahm, Aniza Puteri Mahyuddin, Ghayathri Balasundaram, Mahesh Choolani, and Malini Olivo. "Rapid and sensitive detection of disease biomarkers using SERS assay in a simplified Raman POC device." In Optical Diagnostics and Sensing XXIII: Toward Point-of-Care Diagnostics, edited by Gerard L. Coté. SPIE, 2023. http://dx.doi.org/10.1117/12.2664254.
Повний текст джерелаTanke, Hans J., Michel Zuiderwijk, Karien C. Wiesmeijer, Robert N. Breedveld, William R. Abrams, Claudia J. de Dood, Elisa M. Tjon Kon Fat, and Paul L. A. M. Corstjens. "The use of upconverting phosphors in point-of-care (POC) testing." In SPIE BiOS, edited by Daniel L. Farkas, Dan V. Nicolau, and Robert C. Leif. SPIE, 2014. http://dx.doi.org/10.1117/12.2036906.
Повний текст джерелаJiang, Yu, Jayne Wu, and Shigetoshi Eda. "A Rapid and Ultra-sensitive Sensing Strategy based on Tunable Dielectrophoresis for Robust POC Detection." In 2022 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT). IEEE, 2022. http://dx.doi.org/10.1109/hi-poct54491.2022.9744059.
Повний текст джерелаVaradan, Vijay K. "Nanotechnology Based Point-of-Care Diagnostics and Therapeutics for Neurological Disorders." In ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology. ASMEDC, 2010. http://dx.doi.org/10.1115/nemb2010-13014.
Повний текст джерелаKasparick, Martin, Frank Golatowski, and Dirk Timmermann. "A safe and interoperable distributed alarm notification system for PoC medical devices using IEEE 11073 SDC." In 2017 IEEE Healthcare Innovations and Point-of-Care Technologies (HI-POCT). IEEE, 2017. http://dx.doi.org/10.1109/hic.2017.8227633.
Повний текст джерелаCheng, Yu-Hsuan, Charmi Chande, Li Zhenglong, Sreerag Kaaliveetil, and Sagnik Basuray. "Sensitive and Selective Determination of multiple Diagnostic Targets using a Modular, ASSURED POC Platform called ESSENCE." In 2022 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT). IEEE, 2022. http://dx.doi.org/10.1109/hi-poct54491.2022.9744075.
Повний текст джерелаHsu, Chia-Hao, Yue-Da Tsai, Yun-Chi Chen, Ming-Chih Lee, I.-Yu Huang, and Chua-Chin Wang. "A fast FPW allergy analyzer prototype for point of care (POC)." In 2012 IEEE International Conference on Consumer Electronics (ICCE). IEEE, 2012. http://dx.doi.org/10.1109/icce.2012.6161803.
Повний текст джерела